Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.

Yang CC, Tsai MH, Hu HS, Pu SY, Wu RH, Wu SH, Lin HM, Song JS, Chao YS, Yueh A.

Antiviral Res. 2013 May;98(2):228-41. doi: 10.1016/j.antiviral.2013.03.001. Epub 2013 Mar 13.

PMID:
23499649
[PubMed - indexed for MEDLINE]
2.

Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.

Ng CY, Gu F, Phong WY, Chen YL, Lim SP, Davidson A, Vasudevan SG.

Antiviral Res. 2007 Dec;76(3):222-31. Epub 2007 Jul 26.

PMID:
17662475
[PubMed - indexed for MEDLINE]
3.

Identification of a small-molecule inhibitor of dengue virus using a replicon system.

Hsu YC, Chen NC, Chen PC, Wang CC, Cheng WC, Wu HN.

Arch Virol. 2012 Apr;157(4):681-8. doi: 10.1007/s00705-012-1224-z. Epub 2012 Jan 15.

PMID:
22249364
[PubMed - indexed for MEDLINE]
4.

Development and characterization of a stable luciferase dengue virus for high-throughput screening.

Zou G, Xu HY, Qing M, Wang QY, Shi PY.

Antiviral Res. 2011 Jul;91(1):11-9. doi: 10.1016/j.antiviral.2011.05.001. Epub 2011 May 7.

PMID:
21575658
[PubMed - indexed for MEDLINE]
5.

A high-throughput assay using dengue-1 virus-like particles for drug discovery.

Qing M, Liu W, Yuan Z, Gu F, Shi PY.

Antiviral Res. 2010 May;86(2):163-71. doi: 10.1016/j.antiviral.2010.02.313. Epub 2010 Feb 12.

PMID:
20153777
[PubMed - indexed for MEDLINE]
6.

A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease.

Yang CC, Hu HS, Wu RH, Wu SH, Lee SJ, Jiaang WT, Chern JH, Huang ZS, Wu HN, Chang CM, Yueh A.

Antimicrob Agents Chemother. 2014;58(1):110-9. doi: 10.1128/AAC.01281-13. Epub 2013 Oct 21.

PMID:
24145533
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.

van Cleef KW, Overheul GJ, Thomassen MC, Kaptein SJ, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJ, van Rij RP.

Antiviral Res. 2013 Aug;99(2):165-71. doi: 10.1016/j.antiviral.2013.05.011. Epub 2013 Jun 2.

PMID:
23735301
[PubMed - indexed for MEDLINE]
8.

Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity.

Massé N, Davidson A, Ferron F, Alvarez K, Jacobs M, Romette JL, Canard B, Guillemot JC.

Antiviral Res. 2010 Jun;86(3):296-305. doi: 10.1016/j.antiviral.2010.03.010. Epub 2010 Mar 20.

PMID:
20307577
[PubMed - indexed for MEDLINE]
9.

Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication.

Leardkamolkarn V, Sirigulpanit W, Chotiwan N, Kumkate S, Huang CY.

Virus Res. 2012 Feb;163(2):552-62. doi: 10.1016/j.virusres.2011.12.007. Epub 2011 Dec 16.

PMID:
22197424
[PubMed - indexed for MEDLINE]
10.

Narasin, a novel antiviral compound that blocks dengue virus protein expression.

Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.

Antivir Ther. 2011;16(8):1203-18. doi: 10.3851/IMP1884.

PMID:
22155902
[PubMed - indexed for MEDLINE]
11.

High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.

Puig-Basagoiti F, Deas TS, Ren P, Tilgner M, Ferguson DM, Shi PY.

Antimicrob Agents Chemother. 2005 Dec;49(12):4980-8.

PMID:
16304161
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02).

Mosimann AL, de Borba L, Bordignon J, Mason PW, dos Santos CN.

J Virol Methods. 2010 Jan;163(1):147-52. doi: 10.1016/j.jviromet.2009.09.004. Epub 2009 Sep 15.

PMID:
19761796
[PubMed - indexed for MEDLINE]
13.

Antiviral activity of four types of bioflavonoid against dengue virus type-2.

Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.

Virol J. 2011 Dec 28;8:560. doi: 10.1186/1743-422X-8-560.

PMID:
22201648
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.

De Burghgraeve T, Selisko B, Kaptein S, Chatelain G, Leyssen P, Debing Y, Jacobs M, Van Aerschot A, Canard B, Neyts J.

Antiviral Res. 2013 May;98(2):242-7. doi: 10.1016/j.antiviral.2013.01.011. Epub 2013 Mar 5.

PMID:
23470860
[PubMed - indexed for MEDLINE]
15.

Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.

Hao W, Herlihy KJ, Zhang NJ, Fuhrman SA, Doan C, Patick AK, Duggal R.

Antimicrob Agents Chemother. 2007 Jan;51(1):95-102. Epub 2006 Oct 23.

PMID:
17060518
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Extract of Scutellaria baicalensis inhibits dengue virus replication.

Zandi K, Lim TH, Rahim NA, Shu MH, Teoh BT, Sam SS, Danlami MB, Tan KK, Abubakar S.

BMC Complement Altern Med. 2013 Apr 29;13:91. doi: 10.1186/1472-6882-13-91.

PMID:
23627436
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.

Barral K, Sallamand C, Petzold C, Coutard B, Collet A, Thillier Y, Zimmermann J, Vasseur JJ, Canard B, Rohayem J, Debart F, Decroly E.

Antiviral Res. 2013 Sep;99(3):292-300. doi: 10.1016/j.antiviral.2013.06.001. Epub 2013 Jun 12.

PMID:
23769894
[PubMed - indexed for MEDLINE]
18.

Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.

Yang CC, Hsieh YC, Lee SJ, Wu SH, Liao CL, Tsao CH, Chao YS, Chern JH, Wu CP, Yueh A.

Antimicrob Agents Chemother. 2011 Jan;55(1):229-38. doi: 10.1128/AAC.00855-10. Epub 2010 Oct 11.

PMID:
20937790
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling.

Smith JL, Stein DA, Shum D, Fischer MA, Radu C, Bhinder B, Djaballah H, Nelson JA, Früh K, Hirsch AJ.

J Virol. 2014 May;88(10):5533-42. doi: 10.1128/JVI.00365-14. Epub 2014 Mar 5.

PMID:
24599995
[PubMed - indexed for MEDLINE]
20.

High-content assay to identify inhibitors of dengue virus infection.

Shum D, Smith JL, Hirsch AJ, Bhinder B, Radu C, Stein DA, Nelson JA, Früh K, Djaballah H.

Assay Drug Dev Technol. 2010 Oct;8(5):553-70. doi: 10.1089/adt.2010.0321.

PMID:
20973722
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk